Nanjing Well Pharmaceutical Group Co.,Ltd. (SHA:603351)

China flag China · Delayed Price · Currency is CNY
25.33
-0.26 (-1.02%)
Jun 11, 2026, 1:02 PM CST
Market Cap3.47B -8.5%
Revenue (ttm)1.34B +1.9%
Net Income152.02M +2.4%
EPS1.12 +2.8%
Shares Out 135.44M
PE Ratio22.85
Forward PEn/a
Dividend0.60 (2.39%)
Ex-Dividend DateJun 5, 2026
Volume478,556
Open25.50
Previous Close25.59
Day's Range24.94 - 25.50
52-Week Range23.24 - 33.34
Beta0.14
Analystsn/a
Price Targetn/a
Earnings DateAug 25, 2026

About SHA:603351

Nanjing Well Pharmaceutical Group Co.,Ltd. focuses on the research and development, production, and sale of pharmaceutical excipients and synthetic lubricating base oils to the pharmaceutical companies in China. It is involved in the bio-based material manufacturing, sales, and technology development; technical development and consulting; bio-based material technology research and development; biochemical product technology research and development; food and food additive production and sales; and research and development of new material techno... [Read more]

Sector Healthcare
Founded 2000
Employees 718
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603351
Full Company Profile

Financial Performance

In 2025, SHA:603351's revenue was 1.34 billion, an increase of 2.95% compared to the previous year's 1.30 billion. Earnings were 150.97 million, an increase of 3.11%.

Financial Statements